2-(4-chloro-2,5-dimethoxyphenyl)-n-((2-methoxyphenyl)methyl)ethanamine profile

2-(4-chloro-2,5-dimethoxyphenyl)-N-((2-methoxyphenyl)methyl)ethanamine is a chemical compound, but its exact importance for research depends on the context. To give you a more helpful answer, I need some more information:

**Please tell me:**

* **What is your specific area of research?** Are you interested in its pharmacological properties, its use as a synthetic building block, its potential as a drug candidate, or something else entirely?
* **What aspect of this compound are you interested in?** Do you want to know about its synthesis, its structure, its biological activity, or something else?

Once I have this information, I can provide you with a much more relevant and informative response.

2-(4-chloro-2,5-dimethoxyphenyl)-N-((2-methoxyphenyl)methyl)ethanamine: a psychotropic drug and hallucinogen; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

ID Source	ID
PubMed CID	46856354
SCHEMBL ID	17287282
MeSH ID	M000609750

Synonym
n-(2-methoxybenzyl)-2-(4-chloro-2,5-dimethoxyphenyl)ethanamine
1227608-02-7
AKOS015918300
2c-c-nbome
9fgw3c260n ,
nbome-2c-c
25c-nbome
cimbi-82
2-(4-chloro-2,5-dimethoxyphenyl)-n-((2-methoxyphenyl)methyl)ethanamine
unii-9fgw3c260n
dea no. 7537
4-chloro-2,5-dimethoxy-n-(2-methoxybenzyl)phenethylamine
benzeneethanamine, 4-chloro-2,5-dimethoxy-n-((2-methoxyphenyl)methyl)-
2-(4-chloro-2,5-dimethoxyphenyl)-n-[(2-methoxyphenyl)methyl]ethanamine
FJFPOGCVVLUYAQ-UHFFFAOYSA-N
SCHEMBL17287282
2-(4-chloro-2,5-dimethoxyphenyl)-n-[(2-methoxyphenyl)methyl]ethan-1-amine
DTXSID10676790
25-c-nbome
Q980120
PD046559

Timeframe	Studies, This Drug (%)	All Drugs %
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	16 (80.00)	24.3611
2020's	4 (20.00)	2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Publication Type	This drug (%)	All Drugs (%)
Trials	0 (0.00%)	5.53%
Reviews	2 (9.52%)	6.00%
Case Studies	7 (33.33%)	4.05%
Observational	0 (0.00%)	0.25%
Other	12 (57.14%)	84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Substance	Relationship Strength	Studies	Classes	Roles
phenethylamine phenethylamine: RN given refers to parent cpd; structure in Merck Index, 9th ed, #7016. 2-phenylethylamine : A phenylethylamine having the phenyl substituent at the 2-position.	2.76	2	alkaloid; aralkylamine; phenylethylamine	Escherichia coli metabolite; human metabolite; mouse metabolite
monomethylpropion monomethylpropion: metabolite of dimethylpropion; structure given in first source. 2-methylamino-1-phenylpropan-1-one : An aromatic ketone that is propiophenone in which the hydrogen alpha- to the keto group has been replaced by a methylamino group.. methcathinone : A racemate comprising equal amounts of (R)- and (S)-methcathinone.	2.15	1	aromatic ketone; secondary amino compound
n-methyl-3,4-methylenedioxyamphetamine N-Methyl-3,4-methylenedioxyamphetamine: An N-substituted amphetamine analog. It is a widely abused drug classified as a hallucinogen and causes marked, long-lasting changes in brain serotonergic systems. It is commonly referred to as MDMA or ecstasy.. 3,4-methylenedioxymethamphetamine : A member of the class of benzodioxoles that is 1,3-benzodioxole substituted by a 2-(methylamino)propyl group at position 5.	2.15	1	amphetamines; benzodioxoles	neurotoxin
ketamine Ketamine: A cyclohexanone derivative used for induction of anesthesia. Its mechanism of action is not well understood, but ketamine can block NMDA receptors (RECEPTORS, N-METHYL-D-ASPARTATE) and may interact with sigma receptors.. ketamine : A member of the class of cyclohexanones in which one of the hydrogens at position 2 is substituted by a 2-chlorophenyl group, while the other is substituted by a methylamino group.	2.11	1	cyclohexanones; monochlorobenzenes; secondary amino compound	analgesic; environmental contaminant; intravenous anaesthetic; neurotoxin; NMDA receptor antagonist; xenobiotic
lysergic acid diethylamide Lysergic Acid Diethylamide: Semisynthetic derivative of ergot (Claviceps purpurea). It has complex effects on serotonergic systems including antagonism at some peripheral serotonin receptors, both agonist and antagonist actions at central nervous system serotonin receptors, and possibly effects on serotonin turnover. It is a potent hallucinogen, but the mechanisms of that effect are not well understood.. lysergic acid diethylamide : An ergoline alkaloid arising from formal condensation of lysergic acid with diethylamine.	2.25	1	ergoline alkaloid; monocarboxylic acid amide; organic heterotetracyclic compound	dopamine agonist; hallucinogen; serotonergic agonist
dimethoxyphenylethylamine Dimethoxyphenylethylamine: A derivative of phenethylamine containing two substituent methoxy groups in the phenyl ring.. 3,4-dimethoxyphenylethylamine : An aromatic ether that is the derivative of 2-phenylethylamine with methoxy substituents at the 3- and 4-positions. It is an alkaloid isolated from the Cactaceae family.	3.53	7	alkaloid; aromatic ether; phenylethylamine	allergen; plant metabolite
4-fluoroamphetamine 4-fluoroamphetamine: RN given refers to parent cpd without isomeric designation	2.6	1
methamphetamine Methamphetamine: A central nervous system stimulant and sympathomimetic with actions and uses similar to DEXTROAMPHETAMINE. The smokable form is a drug of abuse and is referred to as crank, crystal, crystal meth, ice, and speed.. methamphetamine : A member of the class of amphetamines in which the amino group of (S)-amphetamine carries a methyl substituent.	2.58	2	amphetamines; secondary amine	central nervous system stimulant; environmental contaminant; neurotoxin; psychotropic drug; xenobiotic
cathinone cathinone: alkaloid from khat shrub, Catha edulis; RN given refers to parent cpd without isomeric designation. cathinone : The S stereoisomer of 2-aminopropiophenone.	2.15	1	2-aminopropiophenone; monoamine alkaloid	central nervous system stimulant; psychotropic drug
2-(4-bromo-2,5-dimethoxyphenyl)ethylamine 2-(4-bromo-2,5-dimethoxyphenyl)ethylamine: behaves as a partial agonist toward both alpha1-adrenergic & 5-HT(2) serotonergic receptors. 2,5-dimethoxy-4-bromophenethylamine : A 2-arylethylamine compound where the aryl moiety is 4-bromo-2,5-dimethoxyphenyl.	2.52	2	2-arylethylamine
4-methoxymethcathinone 4-methoxymethcathinone: structure in first source	2.15	1
2-(4-iodo-2,5-dimethoxyphenyl)-n-(2-methoxybenzyl)ethanamine 2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine: a PET radioligand and 5-HT(2A) receptor agonist; also used as a designer drug; structure in first source	3.39	6
4-iodo-2,5-dimethoxy-beta-phenethylamine 4-iodo-2,5-dimethoxy-beta-phenethylamine: structure in first source	2.1	1
naphyrone 1-naphthalen-2-yl-2-pyrrolidin-1-ylpentan-1-one: a monoamine uptake inhibitor; structure in first source	2.15	1
2,5-dimethoxy-4-n-propylthiophenethylamine 2,5-dimethoxy-4-n-propylthiophenethylamine: structure in first source	2.15	1
mephedrone mephedrone: a beta-keto (bk) designer drug; Central Nervous System Stimulants. mephedrone : An aromatic ketone that is propiophenone substituted at C-4 and at C-beta with methyl and methylamino groups respectively. It is a synthetic stimulant and entactogen drug of the amphetamine and cathinone classes.	2.15	1	amphetamines; aromatic ketone; secondary amino compound	environmental contaminant; xenobiotic
methylone [no description available]	2.15	1	benzodioxoles
4-fluoromethcathinone 4-fluoromethcathinone: structure in first source	2.15	1

Condition	Relationship Strength	Studies
Diathesis [description not available]	2.6	1
Chemical Dependence [description not available]	3.45	2
Drowning Death that occurs as a result of anoxia or heart arrest, associated with immersion in liquid.	2.15	1
Substance-Related Disorders Disorders related to substance use or abuse.	3.45	2
Cardiac Toxicity [description not available]	2.21	1
Cardiac Diseases [description not available]	2.21	1
Heart Diseases Pathological conditions involving the HEART including its structural and functional abnormalities.	2.21	1
Cardiotoxicity Damage to the HEART or its function secondary to exposure to toxic substances such as drugs used in CHEMOTHERAPY; IMMUNOTHERAPY; or RADIATION.	2.21	1
Encephalopathy, Toxic [description not available]	2.1	1
Convulsions, Grand Mal [description not available]	2.1	1
Epilepsy, Tonic-Clonic A generalized seizure disorder characterized by recurrent major motor seizures. The initial brief tonic phase is marked by trunk flexion followed by diffuse extension of the trunk and extremities. The clonic phase features rhythmic flexor contractions of the trunk and limbs, pupillary dilation, elevations of blood pressure and pulse, urinary incontinence, and tongue biting. This is followed by a profound state of depressed consciousness (post-ictal state) which gradually improves over minutes to hours. The disorder may be cryptogenic, familial, or symptomatic (caused by an identified disease process). (From Adams et al., Principles of Neurology, 6th ed, p329)	2.1	1
MODS [description not available]	2.1	1
Multiple Organ Failure A progressive condition usually characterized by combined failure of several organs such as the lungs, liver, kidney, along with some clotting mechanisms, usually postinjury or postoperative.	2.1	1
Drug Overdose Accidental or deliberate use of a medication or street drug in excess of normal dosage.	3.71	3
Glue Abuse [description not available]	2.11	1

2-(4-chloro-2,5-dimethoxyphenyl)-n-((2-methoxyphenyl)methyl)ethanamine

Description

Cross-References

Synonyms (21)

Research

Studies (20)

Market Indicators

Research Demand Index: 11.48

Study Types